News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abcam plc (ABC.L) Named AIM Company of the Year


10/14/2013 8:13:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge UK, October 14, 2013: Abcam Plc., a leading provider of life science research tools, announced today it has been named ‘Company of the Year’ in the 2013 AIM Awards. The AIM awards celebrate outstanding achievement of quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.

Company of the Year is the ultimate accolade for any AIM-listed company. The award is presented to the company that has best demonstrated it is a responsible, fully accountable, dynamic business with strong growth prospects and a commitment to AIM. Above all, the winner is deemed to be a well-managed business, having attracted public funding to enhance and develop its growth potential to the full.

“We’re celebrating 15 years of successful growth at Abcam in 2013, which we credit to a sustainable business model combined with attracting talented employees, who demonstrate exceptional teamwork and a shared passion for providing the best products and services to our customers across the globe,” commented Dr. Jonathan Milner, CEO of Abcam. “This is an exciting time for Abcam as we strive to continue to develop novel solutions to support scientists with their discoveries. I look forward to reporting Abcam’s achievements over the next 15 years.”

Abcam previously won Company of the Year in the 2009 AIM Awards, and has continued to achieve strong growth and shown innovation in the market. The Company has enhanced its product range through the addition of non-primary antibodies, as well as pioneering research tools such as its proprietary rabbit monoclonal antibody technology, RabMAb®, following the acquisition of Epitomics. Abcam’s vision is to become the world’s leading supplier of life science research tools.

To find out more, please visit www.abcam.com.

Contacts:

Abcam

Francesca Axe

T: +44 (0) 1223 696000

Media enquiries

Katie Odgaard

Zyme Communications

E: katie.odgaard@zymecommunications.com

T: +44 (0) 7787 502 947

About Abcam

Abcam plc is a leading provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company’s catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices enabling local services, multi-language support and next-day delivery to over 100 countries. The Company was founded in 1998, and now employs over 700 FTEs. Abcam was admitted to AIM in 2005 (AIM:ABC).

To find out more, please visit www.abcam.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES